Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Clinical Trial

Results published today in the Journal of Psychopharmacology, show that MDMA-Assisted Psychotherapy (3,4-methylenedioxymethamphetamine) was well tolerated by all participants. No unexpected adverse events were observed, and psychosocial functioning improved across the cohort.

By |2021-02-20T00:31:37-08:00February 20, 2021|MDMA, Studies|0 Comments

Magic Mushroom Compound Psilocybin Found Safe for Consumption in Largest Ever Controlled Study

The largest controlled study of psilocybin the psychoactive ingredient in magic mushrooms has found the compound safe for human consumption, bringing researchers one step closer to developing a psilocybin-based treatment for depression.

Groundbreaking Psychedelic Research Gains Momentum, Early Trial Suggests Microdosing LSD is Safe

Psychedelics have been long neglected as the subject of vigorous [...]

By |2019-12-19T09:16:29-08:00December 19, 2019|Articles & News, Dosing Articles, LSD|0 Comments

Feeling Depressed? Psychedelic Magic Mushrooms May the Answer Study Supports

A study shows that ingesting tiny dosages of psilocybin, a hallucinogen that normally occurs in supposed "magic mushrooms," can actually "reset" the mind of a clinically depressed person.

By |2019-11-21T09:39:23-08:00November 21, 2019|Articles & News, Magic Mushrooms|0 Comments


Go to Top